Owner Novartis AG IRM, LLC

Inventors Ding, Qiang; Kanazawa, Takanori; Steensma, Ruo; Zhang, Qiong; Chopiuk, Greg; Matsuura, Naoko; Umemura, Ichiro; Gray, Nathanael Schiander; Jiang, Jiqing; Masuya, Keiichi; Ohmori, Osamu; GarciaEcheverria, Carlos; Karanewsky, Donald; Miyake, Takahiro; Kawahara, Eiji; Wan, Yongqin

Agent Davies Collison Cave

Pub. Number AU-B-2008229685

Parent 2004264382

Filing date 29 September 2008

Wipo publication date 30 October 2008

Acceptance publication date 28 July 2011

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms